首页|基于液质联用探讨COMMD9对高糖环境下肝细胞癌的影响

基于液质联用探讨COMMD9对高糖环境下肝细胞癌的影响

扫码查看
目的 基于液质联用及生物信息学的方式,分析高糖培养条件下的差异蛋白,探讨该环境下导致糖尿病和肝癌发生发展的共同通路。方法 采用定量蛋白质组学和高通量基因芯片和非标记定量质谱分析,比较高糖和常规培养条件下肝癌细胞的蛋白肽段表达差异,筛选差异表达蛋白并差异蛋白富集分析。应用TCGA数据库中肝癌的基因表达矩阵进行后续差异基因的分析。结果 差异蛋白主要富集在代谢相关的信号通路表达上。高糖培养的条件下,肝癌细胞可能通过活跃的脂质代谢重编程促进肿瘤的生长和增殖。通过对LC-MS/MS的差异表达蛋白进行筛选,发现COMMD9在高糖环境下高表达。通过TCGA数据库分析,同样验证了COMMD9在肝癌组织中高表达,且COMMD9以及T分期可以作为肝癌的预后的独立危险因素。结论 通过液质联用的方式合并生物信息学分析,发现高糖环境下COMMD9的高表达可促进肝癌细胞的增殖和代谢重编程,影响肝癌患者的预后,COMMD9有望成为肝癌合并糖尿病的潜在治疗靶点。
Objective To analyze differential proteins under high-glucose culture conditions using liquid chromatography-mass spectrometry and bioinformatics,and to explore the common pathways leading to the development of diabetes and liver cancer in this environment.Methods Using quantitative proteomics,high-throughput gene chips,and unlabeled quantitative mass spectrometry analysis,we compared the differential expression of protein peptides in liver cancer cells under high glucose and conventional culture conditions,screened for differentially expressed proteins,and performed differential protein enrichment analysis.Utilize the gene expression matrix of liver cancer in the TCGA database for subsequent analysis of differentially expressed genes.Results Differential proteins were mainly enriched in the expression of metabolic related signaling pathways.Under high glucose cultivation conditions,liver cancer cells might promote tumor growth and proliferation through active lipid metabolism reprogramming.Through screening of differentially expressed proteins by LC-MS/MS,it was found that COMMD9 is highly expressed in a high glucose environment.Through analysis of the TCGA database,it was also confirmed that COMMD9 is highly expressed in liver cancer tissues,and COMMD9 and T staging can serve as independent risk factors for the prognosis of liver cancer.Conclusion By means of LC-MS and bioinformatics analysis,it is found that the high expression of COMMD9 in high glucose environment can promote the proliferation and metabolic reprogramming of liver cancer cells,and affect the prognosis of liver cancer patients.COMMD9 is expected to become a potential therapeutic target for liver cancer with diabetes.

Hepatocellular carcinomaDiabetesProteomicsCOMMD9Prognosis

唐梅、肖遵强、董萌萌、曹黎东

展开 >

310014 浙江省人民医院(杭州医学院附属人民医院)

肝癌 糖尿病 蛋白质组学 COMMD9 预后

2024

浙江临床医学
浙江中医药大学 浙江省科普作家协会医学卫生委员会

浙江临床医学

影响因子:0.52
ISSN:1008-7664
年,卷(期):2024.26(10)